Infectious Diseases

Back to articles

PPIs decrease the effectiveness of hepatitis C antivirals

March 13, 2018
  • Advising on this article:
  • Allana Sucher

KEY POINT

Sustained virologic responses (SVRs) were lower in patients with hepatitis C taking direct-acting antivirals with proton pump inhibitors (PPIs) compared with those not receiving PPIs, according to results of a comprehensive review published in the Journal of Clinical and Translational Hepatology.

 

SOURCES

Wijarnpreecha K, et al. Efficacy and safety of direct-acting antivirals in hepatitis C virus–-infected patients taking proton pump inhibitors. J Clin Transl Hepatol. 2017;5(4):327–34.

Harvoni [package insert]. Foster City, CA: Gilead; 2017. Accessed February 18, 2018.

Epclusa [package insert]. Foster City, CA: Gilead; 2017. Accessed February 18, 2018.

Recent Articles

2215 Constitution Avenue NW, Washington, DC 20037 Telephone 202-628-4410 Fax 202-783-2351

© 2013 American Pharmacists Association All Rights Reserved.

About the American
Pharmacists Association

The American Pharmacists Association (APhA) is the organization whose members are recognized in society as essential in all patient care settings for optimal medication use that improves health, wellness and quality of life. Through information, education and advocacy, APhA empowers its members to improve medication use and advance patient care.

More info

About APhA DrugInfoLine

APhA DrugInfoLine (ISSN 2162-3015) is a weekly publication of, and is owned and copyrighted by the American Pharmacists Association, the national professional society of pharmacists. Materials in APhA DrugInfoLine do not neccessarily represent the policy, recommendations, or endorsement of APhA. The publisher, authors, editors, reviewers, and contributors have taken care to ensure that the information contained in APhA DrugInfoLine is accurate and current; however, they shall have no ability to any person or entity with regard to claims, losses, or damage caused or alleged to be caused, directly or indirectly by use of any information contained in the publication. All decisions about drug therapy must be based on independent judgement of the clinician.